The company said Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions segment on April 28, 2025. He will assist with the leadership transition until June 1, 2025, when he will separate from the company, according to the 8-K filing.

1. 01

   The company said Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions segment on April 28, 2025. He will assist with the leadership transition until June 1, 2025, when he will separate from the company, according to the 8-K filing.

2. 02

   Nordson said on April 28, 2025 that Justin Hall has been promoted to Executive Vice President and Medical and Fluid Solutions (MFS) segment leader. The press release said Hall joined Nordson in 2006.

3. 03

   The company said Justin Hall joined its Industrial Coating Systems business as an application engineer in 2006 and was promoted to general manager of Nordson MEDICAL Fluid Components in 2020. He most recently served as vice president of the Electronics Processing Systems business.

4. 04

   The company said President and Chief Executive Officer Sundaram Nagarajan believes Hall and the medical leadership team will return the segment to above-market growth. The press release said the Atrion acquisition in 2024 further enhanced the customer offering.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.